First combination COVID-19 and influenza self-tests approved for Australia

7 September 2022 - The TGA has approved the first two nasal combination self-tests (for use at home) that detect ...

Read more →

PHARMAC widens flu vaccine access to increase uptake

27 June 2022 - PHARMAC today announced that it is permanently widening access to the annual funded flu vaccine to people ...

Read more →

FDA authorises first COVID-19 test available without a prescription that also detects influenza and RSV

16 May 2022 - The EUA authorises at home sample collection with testing performed in a laboratory. ...

Read more →

Concerns two different flu vaccines create two tier system for 65 and overs

8 April 2022 - PHARMAC is being accused of kicking an own goal on flu jabs, after those aged 65 ...

Read more →

Seqirus receives Health Canada approval for expanded age indication of its cell-based quadrivalent influenza vaccine for people as young as six months

28 March 2022 - Seqirus announced today that it has received Health Canada approval of Flucelvax Quad (influenza vaccine), its cell-based ...

Read more →

2022 seasonal influenza vaccines

25 March 2022 - The Australian Influenza Vaccine Committee has reviewed data related to epidemiology, antigenic and genetic characteristics of recent ...

Read more →

ProCare supports PHARMAC’s proposal to widen access to the flu vaccine

18 March 2022 - Leading health care provider ProCare has today made a submission in support of PHARMAC’s proposal to ...

Read more →

PHARMAC proposes widened access to the flu vaccine for Māori and Pacific peoples for 2022 season

8 March 2022 - PHARMAC is consulting on a proposal to widen access to the funded influenza vaccine to include Māori ...

Read more →

Flu vaccine price increase

1 March 2022 - PHARMAC has confirmed that the purchase price of the annual influenza vaccine will increase by $2 ...

Read more →

Update of EU recommendations for 2021–2022 seasonal flu vaccine composition

28 June 2021 - EMA has issued an update of the EU recommendations for the influenza virus strains that vaccine ...

Read more →

Flu vaccine war: chemists accused of delivering weaker jab

27 April 2021 - A war has broken out between chemists and doctors, who say elderly Australians are being given an ...

Read more →

Seqirus ready to reinforce Canada's influenza pandemic preparedness plans

23 March 2021 - Health Canada's approval of Foclivia (an adjuvanted, egg-based A strain H5N1 pandemic influenza vaccine) meets key requirement ...

Read more →

Super flu vaccine gets the go-ahead

24 March 2021 - A new type of cell-based influenza vaccine is available this winter that promises to be significantly ...

Read more →

Influenza or the COVID vaccines Pfizer or AstraZeneca — which jab should Australians get first?

16 February 2021 - Australians are being advised to wait two weeks between getting the flu jab and COVID-19 vaccine ...

Read more →

CHMP recommends approval of Supemtek (quadrivalent recombinant influenza vaccine) for the prevention of influenza in adults aged 18 years and older

22 September 2020 - Positive opinion based on clinical data demonstrating safety and efficacy of Supemtek for adults aged 18 and ...

Read more →